Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Says Surge in Service Receipts Drove Q2 Revenue Growth

NEW YORK, Aug. 8 - Orchid Biosciences today reported a surge in total second-quarter revenues atop decreased R&D spending and a widened net loss.


For the period ended June 30, Orchid said that total revenues increased to $16.4 million from $6.7 million in the same quarter one year ago. The dramatic increase was primarily due to strong SNP and identity-genomics services, which grew in the current second quarter to $13.5 million from $4.4 million one year ago, the company said.


Revenue from product sales also increased to $2.3 million from $1.2 million in the second quarter 2001, while receipts from collaborations and licenses in the second quarter fell to $624,000 from $1 million, according to Orchid.


The company said it spent $6.2 million on R&D in the current second quarter, a decrease from the $9.2 million it posted in the same period 2001.


Net loss shrank to $12 million, or $.22 per share, from $14 million, or $.41 per share, in the year-ago period, Orchid said.


The company reported having about $24 million in cash, cash equivalents, and short-term investments and restricted cash as of June 30.


Click here for more information.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.